Eurofins Scientific SE (ERF.PA) Comparison with companies in other sectors?

Eurofins Scientific SE has a share price of 175.96M. You can analyze Eurofins Scientific SE (ERF.PA) competitors across different market sectors through stock heatmaps.

What are ERF.PA's NET and operating margins?

Eurofins Scientific SE (ERF.PA) operating margin is around 0.10, and net profit margin is approximately 0.04 as of the latest reports.

In what way does ERF.PA's earnings per share (EPS) trend reflect its financial momentum?

Eurofins Scientific SE (ERF.PA) EPS is 2.09 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Eurofins Scientific SE is 30.32, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Eurofins Scientific SE?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Eurofins Scientific SE like P/E which is 42.09, P/B which is 2.23, and PEG which is 5.18. Compare them with sector averages to evaluate if the stock is priced fairly.

Eurofins Scientific SE

ERF.PA•EURONEXT

Healthcare

Medical - Diagnostics & Research

€63.36

€1.78(2.89%)

Fundamental Analysis of Eurofins Scientific SE (ERF.PA)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$2.09

P/E Ratio

30.32

ROE

0.05%

Net Margin

0.04%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$11.15B

Shares OutstandingTotal number of shares issued

$175.96M

Book Value/ShareNet worth per share

$28.67

Revenue/ShareAnnual revenue per share

$37.008

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$2.09

Net MarginNet income as percentage of revenue

4.07%

Operating MarginOperating income as percentage of revenue

10.45%

ROEReturn on shareholders' equity

5.34%

ROAReturn on total assets

2.60%

ROCEReturn on capital employed

8.27%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$4.19

Cash/ShareCash and equivalents per share

$3.27

FCF YieldFree cash flow as percentage of market cap

7.05%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$0.60

Dividend YieldAnnual dividend as percentage of stock price

0.95%

Financial Ratios Analysis data is not available for ERF.PAFinancial Ratios Analysis details for ERF.PA are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for ERF.PASector Benchmarking details for ERF.PA are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Eurofins Scientific SE Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Eurofins Scientific SE. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Eurofins Scientific SE's unique business strengths and challenges.

Key Financial Metrics for Eurofins Scientific SE

For Eurofins Scientific SE, essential financial indicators include EPS 2.09, PE 30.32, and ROE 0.05. These key ratios reveal insights into Eurofins Scientific SE's profitability, valuation, and operational health. Understanding these metrics enables you to compare Eurofins Scientific SE with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Eurofins Scientific SE

Metrics like Net Margin 4.07% and ROA 2.60% shed light on how well Eurofins Scientific SE is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Eurofins Scientific SE can sustain its operations and continue growing in the future.

Valuation and Market Position of Eurofins Scientific SE

Using ratios such as P/B Ratio 2.23 and PEG Ratio 5.18, investors can assess whether Eurofins Scientific SE is appropriately valued based on its financials and growth potential. These figures, combined with Eurofins Scientific SE's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Eurofins Scientific SE

Financial health indicators, such as Debt/Equity Ratio 0.68 and Cash Flow $4.19, provide a snapshot of Eurofins Scientific SE's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Eurofins Scientific SE, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Eurofins Scientific SE

Investing in Eurofins Scientific SE based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Eurofins Scientific SE focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;